Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, YS | - |
dc.contributor.author | Lee, BH | - |
dc.contributor.author | Park, SJ | - |
dc.contributor.author | Kang, SB | - |
dc.contributor.author | Rhim, H | - |
dc.contributor.author | Park, JY | - |
dc.contributor.author | Lee, JH | - |
dc.contributor.author | Jeong, SW | - |
dc.contributor.author | Lee, JY | - |
dc.date.accessioned | 2024-01-21T06:41:07Z | - |
dc.date.available | 2024-01-21T06:41:07Z | - |
dc.date.created | 2021-09-05 | - |
dc.date.issued | 2004-07-05 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/137413 | - |
dc.description.abstract | For LVA T-type Ca2+ channel blockers, 3,4-dihydroquinazoline derivatives as new scaffolds were prepared and evaluated for the inhibitory activity against two members of the recombinant T-type Ca2+ channel family. Among them, 8a (KYS05001, IC50 = 0-9 muM) was nearly equipotent with mibefradil (IC50 = 0.84 muM) and inhibited LVA T-type Ca2+ channel with greater efficacy than HVA Ca2+ channel. (C) 2004 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | CALCIUM-CHANNELS | - |
dc.subject | PHARMACOLOGICAL-PROPERTIES | - |
dc.subject | THALAMIC NEURONS | - |
dc.subject | IN-VITRO | - |
dc.subject | CARBODIIMIDE | - |
dc.subject | MIBEFRADIL | - |
dc.subject | INHIBITION | - |
dc.subject | THRESHOLD | - |
dc.subject | ALPHA-1H | - |
dc.subject | CONDUCTANCES | - |
dc.title | 3,4-dihydroquinazoline derivatives as novel selective T-type Ca2+ channel blockers | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bmcl.2004.04.090 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.14, no.13, pp.3379 - 3384 | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 14 | - |
dc.citation.number | 13 | - |
dc.citation.startPage | 3379 | - |
dc.citation.endPage | 3384 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000221998100001 | - |
dc.identifier.scopusid | 2-s2.0-2942531077 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | CALCIUM-CHANNELS | - |
dc.subject.keywordPlus | PHARMACOLOGICAL-PROPERTIES | - |
dc.subject.keywordPlus | THALAMIC NEURONS | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | CARBODIIMIDE | - |
dc.subject.keywordPlus | MIBEFRADIL | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | THRESHOLD | - |
dc.subject.keywordPlus | ALPHA-1H | - |
dc.subject.keywordPlus | CONDUCTANCES | - |
dc.subject.keywordAuthor | 3,4-dihydroquinazolines | - |
dc.subject.keywordAuthor | T-type calcium channel | - |
dc.subject.keywordAuthor | blockers | - |
dc.subject.keywordAuthor | mibefradil | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.